The HealthBuddy platform is an enabler for personalized health solutions based on microservice architecture, machine learning, big data analysis and regulatory compliance. The platform enables patient empowerment, a closer collaboration between patients and healthcare professionals, improved treatment adherence, stronger coping capabilities, smarter utilization of healthcare resources, and better outcomes for the patient. Learn more ›
We want people with rheumatoid disease to be able to gain greater control of their disease. For that reason, we invited rheumatologists and patient organizations to join us and co-create a unique tool built through the HealthBuddy platform.
RheumaBuddy is a personal diary and a community. Users can rate their symptoms on a day-to-day basis, and RheumaBuddy summarizes the separate entries and provides a comprehensive overview. In the community embedded in the service, people can offer help and receive advice.
The EULAR award-winning app is available in over 30 countries in Europe, and we are proud to call RheumaBuddy the European market leader.frameworks combined with treatment specifications and knowledge from the different dilemma scenarios. The digital tool supports both patients and physicians in making the right treatment choice in a joint effort. Learn more ›
A group of researchers and young people with cancer based in Rigshospitalet, one of the leading and highly-specialized hospitals in Denmark, called for our help: how can we utilize digital technologies to help both young people with cancer and healthcare professionals? Our solution, which was created during an exciting co-development process with oncologists, young people with cancer and the hospital, is a digital service we call Kræftværket. The tracking tool enables users to receive advice and help in videos and engage in ongoing discussions also from afar. The generated data are used in a combined research and development project that aims to collect data-driven evidence to improve cancer treatments. Learn more ›
As part of the national cancer strategy, the Danish Health Authority is focusing on Shared Decision Making between cancer patients and healthcare professionals. Daman was chosen to transform the idea into a digital solution. Together we co-created Patient Decision Aids (PDAs).
The PDAs are designed for dilemmas patients are facing within breast, lung and colorectal cancer. The development is based on internationally validated frameworks combined with treatment specifications and knowledge from the different dilemma scenarios. The digital tool supports both patients and physicians in making the right treatment choice in a joint effort. Learn more ›